Less Ads, More Data, More Tools Register for FREE

Pin to quick picksToyota Motor Regulatory News (TYT)

Share Price Information for Toyota Motor (TYT)

Share Price is delayed by 15 minutes
Get Live Data
2,824.71174    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap:
TYT Live PriceLast checked at - London Stock Exchange

Intraday Toyota Motor Share Chart

Production Plans in November 2021

15 Oct 2021 08:00

RNS Number : 2143P
Toyota Motor Corporation
15 October 2021
Β 

October 15, 2021

TOYOTA MOTOR CORPORATION

Β 

Production Plans in November 2021, as of October 15

Β 

At Toyota, we have made repeated adjustments to our production plans since August due to a shortage of parts resulting from the spread of COVID-19, causing various inconveniences to all parties concerned. We would like to express our gratitude to all parties concerned for their immense support in helping us maintain production.

Β 

Our production plans for November are outlined below.

Actual production has remained below planned levels since August. However, with the cooperation of our suppliers,Β we have been thoroughly examining each and every case of possible parts shortage in the supply chain. As a result, global production volume in November is expected to reach 850,000 to 900,000 units. (Reference: Global production volumes were approximately 830,000 units in November 2020 and approximately 500,000 to 600,000 units each in September and October 2021)

Β 

Aiming to make up for previous production shortfalls, we had initially planned to produce approximately 1 million units, which is a higher production level. However, since we are still experiencing a shortage of some parts and will be unable to make up for previous production shortfalls, we have adjusted our initial production plans for November. This adjustment will affect approximately 50,000 units in Japan, and between 50,000 units and 100,000 units overseas; the total number of units affected globally will be between approximately 100,000 units and 150,000 units.

Β 

In response to the continuing shortage of some parts, we will continue our efforts to strengthen our supply chain. We will implement thorough anti-COVID-19 measures both at our own plants and at our suppliers, and since we expect the shortage of semiconductors to continue in the long-term, we will consider the use of substitutes where possible. In this way, we will do everything we can to ensure we deliver as many cars to our customers as quickly as possible.

Β 

Regarding our full-year production forecast for the fiscal year ending March 31, 2022, we expect to maintain around 9 million units due to the easing of restrictions on COVID-19 in Southeast Asia, and the production cutback in September and October is expected to be 100,000 to 150,000 units, a smaller amount than previously announced.

Β 

Domestic production adjustments for November are detailed in the table below. We would like to offer our sincerest apologies to our customers and our suppliers for the various inconveniences these adjustments may cause.

Β 

Β 

Β 

Suspension of operations in November (6 lines in 4 plants out of 28 lines in 14 plants)

Β 

Plants

Period of production suspension

Production vehicle

Toyota Motor Corporation

Tsutsumi Plant

Production line #2

<One day>

5 (Fri)

Corolla Sport,

Camry, ES

Toyota Motor Kyushu

Miyata Plant

Production line #1

<Two days>12 (Fri) , 19 (Fri)

NX, CT, UX, UX300e

Production line #2

<One day>12 (Fri)

ES, RX

Toyota Motor East Japan

Iwate Plant

Production line #1

<Five days>

4 (Thu), 5 (Fri), 8 (Mon), 12 (Fri), 15 (Mon)

C-HR, Aqua

Production line #2

<Four days>

4 (Thu), 5 (Fri), 8 (Mon), 12 (Fri)

Yaris, Yaris Cross, Aqua

Miyagi Ohira Plant

Yaris Cross, Sienta,

Corolla Axio,Corolla Fielder,

JPN Taxi

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STRUVRNRAAURARA
Date   Source Headline
23rd Jun 20269:26 amRNSStabilisation Notice
22nd Jun 20269:49 amRNSStabilisation Notice
18th Jun 20268:00 amRNSResolutions Adopted at Shareholders’ Meeting
18th Jun 20268:00 amRNSVoting Results of General Shareholders' Meeting
18th Jun 20268:00 amRNSNotice of Partial Amendment to the ESOP trust
17th Jun 20269:00 amRNSChanges to Board Members and Executive Structure
17th Jun 20269:00 amRNSCorporate Governance Report
15th Jun 20268:00 amRNSRecording of Gains on Sale of Shares
10th Jun 20268:00 amRNSExecutive Summary of the Securities report
28th May 202611:30 amRNSNotice Concerning Company Split
20th May 20265:30 pmRNSNotice Concerning Company Split
13th May 20268:00 amRNSNotice of Convocation
8th May 20268:00 amRNSFY2026 Presentation Documents
8th May 20268:00 amRNSFY2026 Financial Summary
8th May 20268:00 amRNSDisposition of Treasury Stock
8th May 20268:00 amRNSGeneral Shareholders’ Meeting
28th Apr 20269:00 amRNSTender Offer Results and Completion of Repurchase
30th Mar 20268:00 amRNSTender Offer for Own Shares / Repurchase of Shares
6th Mar 20268:00 amRNSConcerning Changes of Tender Offer for Own Shares
5th Mar 20268:00 amRNSExecutive and senior management change notice
25th Feb 20268:00 amRNSShareholder Benefits (Record Date: 31 Mar. 2026) 
6th Feb 20268:00 amRNSFY2026 3rd Quarter Financial Summary
6th Feb 20268:00 amRNSFY2026 3rd Quarter Financial Results Presentation
6th Feb 20268:00 amRNSNotification of Change of Representative Directors
14th Jan 20269:00 amRNSConcerning Changes of Tender Offer for Own Shares
28th Nov 20258:00 amRNSFinancial Statements (FY2025 First Half)
28th Nov 20258:00 amRNSSummary of First Half Secrities Report
5th Nov 20258:00 amRNSFY2026 2nd Quarter Financial Results Presentation
5th Nov 20258:00 amRNSFY2026 2nd Quarter Financial Summary
6th Oct 202510:00 amRNSConcerning Progress of Tender Offer for Own Shares
9th Sep 20258:00 amRNSProgress Report on Measures to Prevent Recurrence
7th Aug 20258:00 amRNSFY2026 1st Quarter Financial Results Presentation
7th Aug 20258:00 amRNSFY2026 1st Quarter Financial Summary
7th Aug 20258:00 amRNSTreasury Stock Disposition for Compensation Plan
18th Jun 20251:00 pmRNSSummary of Annual Securities Report
18th Jun 20259:00 amRNSCorporate Governance Report
13th Jun 20258:00 amRNSVoting Results of General Shareholders' Meeting
13th Jun 20258:00 amRNSResolutions Adopted at Shareholders’ Meeting
12th Jun 20258:00 amRNSNotification of changes to Executive Structure
10th Jun 20259:00 amRNSNotice About Change in Consolidated Subsidiary
3rd Jun 20258:00 amRNSTender Offer for Own Shares and Other Matters
30th May 20259:30 amRNSprogress report on recurrence prevention measures
28th May 20258:00 amRNSOur View on ISSs Voting Recommendation
13th May 20258:00 amRNSNotice of Convocation
8th May 20259:00 amRNSFY2025 Presentation Documents
8th May 20258:00 amRNSPartial Amendments to Articles of Incorporation
8th May 20258:00 amRNSGeneral Shareholders' Meeting
8th May 20258:00 amRNSFY2025 Financial Summary
8th May 20258:00 amRNSDisposition of Treasury Stock
28th Apr 20257:00 amRNSRegarding Certain Media Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.